24/7 patient support Free consultation →
Get free quote

Bone Marrow Transplant (BMT) in India

Also known as BMT cost India, stem cell transplant India, hematopoietic stem cell transplant (HSCT), autologous transplant, allogeneic transplant, thalassemia bone marrow transplant

Bone Marrow Transplant (BMT) in India
Cost from$14,000 – $38,000 In hospital25-35 days Stay in Indiaabout 6-8 weeks Success70-90% Procedure timeThe infusion itself takes a few hours; it is part of a multi-week hospital process AnaesthesiaNone for the infusion Opinion in24 hours

The short answer

Bone marrow transplant in India costs between $14,000 and $38,000 depending on the type, against $150,000 to $300,000+ in Western countries. Autologous transplants (using the patient's own cells) sit at the lower end, while allogeneic transplants (using donor cells) cost more depending on how closely the donor is matched.

About Bone Marrow Transplant (BMT)

A bone marrow transplant (BMT), also called a hematopoietic stem cell transplant (HSCT), replaces damaged or diseased bone marrow with healthy blood-forming stem cells. It is used to treat certain blood cancers such as leukemia and lymphoma, and non-cancerous conditions such as thalassemia and aplastic anemia. There are two main types: autologous, using the patient's own stem cells, and allogeneic, using stem cells from a donor.

Autologous transplant

In an autologous transplant, the patient's own stem cells are collected and stored before high-dose chemotherapy, which destroys the diseased marrow along with the cancer. The stored stem cells are then infused back to rebuild healthy marrow. Because there's no donor to match, this type generally has a more predictable process and lower cost.

Allogeneic transplant

In an allogeneic transplant, stem cells come from a donor, ideally a fully HLA-matched sibling, or otherwise a matched unrelated donor or a partially matched (haploidentical) family donor. The degree of donor match significantly affects both the cost and the process: a matched sibling donor is the most straightforward and least expensive, a haploidentical (half-matched) donor requires additional preparation, and an unrelated donor found through a registry search adds both time and cost. Allogeneic transplants carry a risk of graft-versus-host disease (GvHD), where the donor's immune cells react against the patient's body, which is monitored and managed closely after transplant.

What the transplant can and cannot do

A successful transplant restores the body's ability to produce healthy blood cells and, for cancer patients, is often the treatment most likely to achieve long-term remission. It is a demanding process: the weeks around transplant carry real risks, including infection, bleeding, and GvHD, and require careful hospital monitoring, which is why the stay is longer than with most surgical procedures.

Why patients choose India for this

Save 80-90% on a complex, high-cost treatment

The same autologous and allogeneic transplant protocols used in leading Western BMT centres are available in India at a fraction of the cost.

High-volume transplant centres

Partner hospitals run dedicated BMT units handling autologous, matched, and haploidentical transplants routinely, not as occasional cases.

Established outcomes for thalassemia and leukemia

India has extensive experience treating conditions common in South Asian and Middle Eastern patient populations, including thalassemia, with success rates comparable to international standards.

Donor search and matching support

For patients without a matched sibling donor, our team helps coordinate donor registry searches and haploidentical options through partner hospitals.

Bone Marrow Transplant (BMT) cost

CountryIndicative cost
India — with Nobel Medi Assistance $14,000 – $38,000
United States$150,000 - $300,000+
United Kingdom$100,000 - $180,000
UAE / Middle East$60,000 - $100,000
Singapore$70,000 - $120,000

Figures are indicative for international patients and depend on the hospital, the surgeon and your reports. Your exact cost is confirmed in writing after a specialist review — free, and with no obligation.

What the estimate covers

Included

  • Haematologist/BMT specialist and transplant team fees
  • Stem cell collection and processing (patient or matched sibling donor)
  • Conditioning chemotherapy before transplant
  • Transplant infusion and isolation ward stay for the planned duration
  • Routine medicines during the hospital stay
  • Post-transplant monitoring before discharge

Not included

  • Diagnostic workup, HLA typing, and staging tests done before arrival in India
  • Flights, visa and travel insurance for the patient and accompanying family
  • Accommodation once discharged from hospital
  • Unrelated donor registry search and donor procurement fees, where applicable
  • Treatment for complications such as graft-versus-host disease (GvHD), if they occur
  • Long-term follow-up care and medication after returning home

How Bone Marrow Transplant (BMT) is done

  1. Evaluation and donor matchingA haematologist confirms the diagnosis and transplant type, and, for allogeneic transplants, HLA typing identifies a matched sibling, haploidentical, or unrelated donor.
  2. Stem cell collectionStem cells are collected from the patient (autologous) or the donor (allogeneic), through a blood draw or bone marrow harvest.
  3. ConditioningThe patient receives high-dose chemotherapy, and sometimes radiation, to destroy the diseased marrow and prepare the body to accept the new stem cells.
  4. Transplant infusionThe collected stem cells are infused into the patient's bloodstream, similar to a blood transfusion.
  5. Engraftment periodOver roughly two to three weeks, the new stem cells travel to the bone marrow and begin producing healthy blood cells, monitored closely in an isolation ward.
  6. Monitoring for complicationsThe patient is closely watched for infection, bleeding, and, in allogeneic cases, signs of graft-versus-host disease.
  7. Discharge and follow-up planOnce blood counts recover sufficiently and the patient is stable, they are discharged with a detailed monitoring and medication plan.

Recovery and what to expect

  • Conditioning phase (about a week)High-dose chemotherapy given before the transplant, with close monitoring for side effects.
  • Transplant dayStem cell infusion, generally a straightforward process similar to a blood transfusion.
  • Engraftment (2-3 weeks)The most vulnerable period, with a very low blood count and high infection risk, managed in an isolation ward.
  • 25-35 daysDischarged from hospital once blood counts recover and the patient is stable.
  • 4-6 weeks post-dischargeContinued recovery at accommodation in India, with regular monitoring before flying home.
  • 6-12 monthsImmune system gradually strengthens; regular follow-up continues at home, with allogeneic patients monitored longer for GvHD.

Specialists who perform this

Where it is done

Frequently asked questions

What's the difference between autologous and allogeneic transplant?
Autologous uses the patient's own stored stem cells and is generally more predictable and lower cost. Allogeneic uses donor stem cells and costs more depending on how closely the donor matches, since it also carries a risk of graft-versus-host disease.
What if I don't have a matched sibling donor?
Options include a haploidentical (half-matched) family donor or a search through unrelated donor registries. Both add cost and time compared to a matched sibling donor, and our team can help coordinate this search.
How long do we need to stay in India?
Typically 6-8 weeks in total, covering conditioning, the transplant, the engraftment period in hospital, and follow-up monitoring before flying home.
What is graft-versus-host disease?
It's a condition where the donor's immune cells react against the patient's body, seen only in allogeneic transplants. It's actively monitored for and managed if it occurs; treatment for it is not included in the base transplant estimate.
What are the success rates?
This varies significantly by disease, transplant type, and donor match, generally ranging from 70-90%. Your haematologist will give you an individualised estimate based on your specific case.
Is this treatment suitable for thalassemia?
Yes, allogeneic bone marrow transplant is a well-established curative treatment for thalassemia major, particularly when a matched sibling donor is available.
Can a family member stay with the patient during the hospital stay?
Yes, our partner hospitals accommodate an accompanying family member, and our team assists with visa arrangements for this.

What would your Bone Marrow Transplant (BMT) cost?

Send your reports and a senior specialist sends back a written plan with costs within 24 hours. Free, with no obligation.

Get a free opinion Message on WhatsApp